Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
---|
07/24/2012 | US8227575 Cytokine zalpha11 ligand antibodies |
07/24/2012 | US8227413 Compositions and methods for inducing angiogenesis |
07/24/2012 | US8226976 Method of using cell-free protein synthesis to produce a membrane protein |
07/24/2012 | CA2536182C Macrocyclic peptides active against the hepatitis c virus |
07/24/2012 | CA2488167C Prodrugs of excitatory amino acids |
07/19/2012 | WO2012097344A2 Metal abstraction peptide and uses thereof |
07/19/2012 | WO2012096596A1 Antiviral agent |
07/19/2012 | WO2012030217A3 Culture medium for eukaryotic cells |
07/19/2012 | US20120183954 Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates |
07/19/2012 | US20120183570 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions |
07/19/2012 | US20120183554 Biomarker |
07/19/2012 | CA2824151A1 Antigen surrogates in autoimmune disease |
07/19/2012 | CA2814763A1 Compositions comprising enzyme-cleavable oxycodone prodrug |
07/18/2012 | EP2476691A1 Method for manufacturing a lipidic peptide compound |
07/18/2012 | CN102596986A Method for manufacturing a lipidic peptide compound |
07/18/2012 | CN102584941A Paddy rice Ustiloxin A extracting and purifying method |
07/18/2012 | CN102584940A Peptidic compounds |
07/18/2012 | CN102584939A Peptidic compounds |
07/18/2012 | CN102584938A Crystallizing method of aspartame |
07/18/2012 | CN102584937A Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
07/18/2012 | CN101863958B Induction of the mitochondrial permeability transition |
07/18/2012 | CN101440124B Methods for preventing mitochondrial permeability transition |
07/18/2012 | CN101273030B Macrocyclic inhibitors of hepatitis C virus |
07/17/2012 | US8222392 Kit for detection of telomerase reverse transcriptase nucleic acids |
07/17/2012 | US8222201 Crystalline form of linaclotide |
07/17/2012 | US8221969 Method of producing virus |
07/17/2012 | CA2522561C Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors |
07/17/2012 | CA2277486C Synthetic antibiotics |
07/12/2012 | US20120177780 Method for improving bread-making properties of rice flour bread dough |
07/12/2012 | US20120177580 Metal Abstraction Peptide (MAP) Tag and Associated Methods |
07/11/2012 | EP2473517A1 Transglutaminase-activating peptide, and cosmetic or pharmaceutical composition containing same |
07/11/2012 | EP2473516A1 Antibiotic compounds |
07/11/2012 | EP1300416B1 Memory-enhancing peptides and the use thereof |
07/11/2012 | CN102574892A Antibiotic compounds |
07/11/2012 | CN102558302A Method for separating and purifying pristinamycin |
07/11/2012 | CN102558299A Synthetic polypeptide and application thereof |
07/11/2012 | CN102558298A Method for synthesizing tetrapeptide isomers by using solid phase peptide synthesis method and applications of tetrapeptide isomers |
07/11/2012 | CN102558297A Endomorphin-1 analogue modified by alpha-alkenyl-beta-amino acid and composition and application thereof |
07/11/2012 | CN102558270A 20(S) and 20(R)-dammarane-3beta,12beta,20,25-tetrol derivative and preparation method and application thereof |
07/11/2012 | CN102558165A Smac peptidomimetics useful as iap inhibitors |
07/11/2012 | CN102557989A Ulimorelin intermediate and Ulimorelin preparation method |
07/11/2012 | CN101282978B Macrocylic inhibitors of hepatitis c virus |
07/11/2012 | CN101006097B Vla-4 antagonists |
07/10/2012 | US8217158 Immunotoxin fusion proteins and means for expression thereof |
07/10/2012 | US8217142 Liquid phase peptide synthesis of KL-4 pulmonary surfactant |
07/10/2012 | US8217137 Fullerene-based amino acids |
07/10/2012 | US8217048 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
07/10/2012 | CA2481369C Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease |
07/10/2012 | CA2439101C New medical uses of intercellular communication facilitating compounds |
07/05/2012 | US20120172422 Methods of Treatment Using a Prodrug of an Excitatory Amino Acid |
07/05/2012 | US20120172291 Macrocyclic hepatitis c serine protease inhibitors |
07/05/2012 | US20120172290 Anti-Viral Compounds |
07/04/2012 | EP2471944A1 Novel peptidase substrates |
07/04/2012 | EP2470216A1 Peptide clearing agents |
07/04/2012 | EP2470189A1 Processes for preparing protease inhibitors of hepatitis c virus |
07/04/2012 | EP2178888B1 Proteasome inhibitors |
07/04/2012 | EP1472238B1 Bioluminescent protease assay |
07/04/2012 | CN102533549A Nanogel scaffold material for culturing and desorbing type of cells and preparation method thereof |
07/04/2012 | CN102532262A Preparation of fatty acid-RGD-fatty alcohol conjugate mediated epirubicin targeted liposome and evaluation on anticancer activity |
07/04/2012 | CN102532261A Bone remodeling activator-typrotide and medicament composition and application thereof |
07/04/2012 | CN102532260A Silkworm chrysalis protein source dipeptide DA and uses thereof |
07/04/2012 | CN102532259A Oligopeptide-based cationic lipid derivative and application thereof in pharmaceutical preparation |
07/04/2012 | CN102532198A Antiviral phosphinate compounds |
07/04/2012 | CN102532051A 有丝分裂驱动蛋白抑制剂及其使用方法 Mitotic kinesin inhibitors and methods of use |
07/04/2012 | CN102199111B Process and intermediates for the preparation of hepatitis C virus protease inhibitor |
07/04/2012 | CN101967183B Artificially synthesized novel antithrombotic peptide derivative, preparation method and application thereof |
07/04/2012 | CN101092455B Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
06/28/2012 | WO2012087888A2 Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (g) quinazoline trisodium salt |
06/28/2012 | WO2012085479A1 Process for preparing platinum-carbene complexes |
06/28/2012 | WO2012085475A1 Novel platinum-carbene complexes and use thereof as medicaments |
06/28/2012 | WO2012083436A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa |
06/28/2012 | WO2012083424A1 Novel amino acid linker sequences for ligand immobilization |
06/28/2012 | WO2011135464A3 N-(aminoacyl)-amino compound |
06/28/2012 | US20120165566 Processes for intermediates for macrocyclic compounds |
06/28/2012 | US20120165296 Bisphosphonate-prodrugs |
06/28/2012 | US20120165276 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof |
06/28/2012 | US20120165260 Crystalline ezatiostat hydrochloride ansolvate |
06/28/2012 | US20120165248 Glutathione Derivatives and Their Uses for the Treatment of Viral Diseases |
06/28/2012 | US20120164230 Soluble Nanoparticles as Delivery Systems for Prodrugs |
06/28/2012 | CA2822411A1 Process for preparing platinum-carbene complexes |
06/28/2012 | CA2822410A1 Novel platinum-carbene complexes and use thereof as medicaments |
06/28/2012 | CA2822350A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa |
06/28/2012 | CA2819510A1 Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta(g)quinazoline trisodium salt |
06/27/2012 | EP2468744A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
06/27/2012 | CN102516355A Peptide derivative of benzfuran quinoline and preparation method thereof and application thereof as antitumor medicament |
06/27/2012 | CN101906097B 1,3-dioxane compounds as well as synthesizing method and medical application thereof |
06/27/2012 | CN101497651B Compound with thrombus dissolving activity, as well as preparation and use thereof |
06/26/2012 | US8207299 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof |
06/26/2012 | US8207297 Compounds for enzyme inhibition |
06/26/2012 | US8207131 Peptide |
06/26/2012 | US8207128 Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof |
06/26/2012 | US8207127 Compounds for enzyme inhibition |
06/26/2012 | US8207126 Compounds for enzyme inhibition |
06/26/2012 | US8207125 Compounds for enzyme inhibition |
06/26/2012 | US8207124 Compounds for enzyme inhibition |
06/26/2012 | CA2445875C Pentapeptide compounds and uses related thereto |
06/26/2012 | CA2270448C Method for giving resistance to weed control compounds to plants |
06/26/2012 | CA2237316C Complex cationic lipids |
06/26/2012 | CA2220021C Biologically active peptides and compositions, their use |
06/21/2012 | WO2012061408A3 Method for making macrocycles |